Korea Ratings Corp
KOSDAQ:034950
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
84 216.5284
106 900
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Korea Ratings Corp
| Current Assets | 124.2B |
| Cash & Short-Term Investments | 107.4B |
| Receivables | 15.8B |
| Other Current Assets | 940.5m |
| Non-Current Assets | 52B |
| Long-Term Investments | 30.2B |
| PP&E | 4.7B |
| Intangibles | 4.2B |
| Other Non-Current Assets | 12.8B |
| Current Liabilities | 33.8B |
| Accounts Payable | 120.9k |
| Accrued Liabilities | 13.7B |
| Other Current Liabilities | 20.1B |
| Non-Current Liabilities | 23.2B |
| Long-Term Debt | 986.9m |
| Other Non-Current Liabilities | 22.2B |
Balance Sheet
Korea Ratings Corp
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
17 328
|
8 080
|
19 175
|
10 175
|
11 542
|
11 076
|
12 920
|
15 017
|
102 977
|
114 454
|
110 886
|
102 773
|
115 687
|
|
| Cash |
4
|
3
|
2
|
2
|
6
|
3
|
2
|
1
|
1
|
2
|
2
|
3
|
3
|
|
| Cash Equivalents |
17 324
|
8 077
|
19 173
|
10 173
|
11 536
|
11 073
|
12 918
|
15 016
|
102 976
|
114 452
|
110 884
|
102 771
|
115 684
|
|
| Short-Term Investments |
45 900
|
61 500
|
51 400
|
71 900
|
77 900
|
83 800
|
82 200
|
105 600
|
1 000
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
4 300
|
4 815
|
5 293
|
5 383
|
6 420
|
6 416
|
7 325
|
8 188
|
6 515
|
7 801
|
6 844
|
6 053
|
8 302
|
|
| Accounts Receivables |
3 802
|
4 064
|
4 329
|
4 651
|
5 844
|
5 956
|
6 620
|
7 636
|
5 950
|
7 255
|
6 152
|
5 124
|
7 038
|
|
| Other Receivables |
498
|
751
|
964
|
732
|
576
|
460
|
705
|
552
|
565
|
546
|
692
|
929
|
1 264
|
|
| Other Current Assets |
986
|
1 400
|
1 818
|
1 300
|
111
|
285
|
791
|
729
|
302
|
300
|
236
|
300
|
350
|
|
| Total Current Assets |
68 513
|
75 795
|
77 686
|
88 759
|
95 973
|
101 577
|
103 236
|
129 534
|
110 795
|
122 555
|
117 966
|
109 127
|
124 339
|
|
| PP&E Net |
3 573
|
3 675
|
4 069
|
4 845
|
4 779
|
4 124
|
5 184
|
7 547
|
5 045
|
3 634
|
2 635
|
5 912
|
5 375
|
|
| PP&E Gross |
3 573
|
3 675
|
4 069
|
4 845
|
4 779
|
4 124
|
5 184
|
7 547
|
5 045
|
3 634
|
2 635
|
5 912
|
5 375
|
|
| Accumulated Depreciation |
5 676
|
5 588
|
6 129
|
4 741
|
5 266
|
6 092
|
6 122
|
8 174
|
7 886
|
7 122
|
7 820
|
5 554
|
6 663
|
|
| Intangible Assets |
2 712
|
2 085
|
1 915
|
2 156
|
1 953
|
2 076
|
1 790
|
1 697
|
7 401
|
10 226
|
7 138
|
3 409
|
2 300
|
|
| Goodwill |
685
|
685
|
685
|
685
|
685
|
685
|
685
|
685
|
685
|
685
|
685
|
685
|
685
|
|
| Note Receivable |
2 264
|
2 413
|
2 636
|
2 511
|
2 574
|
2 609
|
2 580
|
3 032
|
2 849
|
3 623
|
3 962
|
5 075
|
5 018
|
|
| Long-Term Investments |
10 824
|
13 024
|
11 970
|
7 480
|
6 599
|
7 654
|
9 310
|
9 845
|
15 661
|
12 173
|
20 747
|
23 966
|
30 213
|
|
| Other Long-Term Assets |
9 330
|
8 111
|
10 590
|
10 098
|
10 148
|
8 942
|
7 942
|
7 997
|
8 175
|
8 443
|
8 178
|
6 925
|
7 395
|
|
| Other Assets |
685
|
685
|
685
|
685
|
685
|
685
|
685
|
685
|
685
|
685
|
685
|
685
|
685
|
|
| Total Assets |
97 901
N/A
|
105 788
+8%
|
109 551
+4%
|
116 535
+6%
|
122 711
+5%
|
127 667
+4%
|
130 727
+2%
|
160 337
+23%
|
150 611
-6%
|
161 338
+7%
|
161 311
0%
|
155 099
-4%
|
175 325
+13%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
321
|
168
|
103
|
77
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
4 302
|
8 871
|
9 170
|
10 632
|
9 182
|
9 956
|
10 636
|
13 257
|
13 356
|
14 447
|
10 936
|
11 327
|
13 575
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
677
|
701
|
657
|
344
|
593
|
638
|
|
| Other Current Liabilities |
20 450
|
8 716
|
9 217
|
9 868
|
9 859
|
10 963
|
12 384
|
14 467
|
15 085
|
17 234
|
16 304
|
13 657
|
16 421
|
|
| Total Current Liabilities |
25 074
|
17 755
|
18 491
|
20 577
|
19 042
|
20 919
|
23 021
|
28 401
|
29 142
|
32 338
|
27 585
|
25 576
|
30 635
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 172
|
790
|
191
|
123
|
1 699
|
1 213
|
|
| Deferred Income Tax |
112
|
671
|
324
|
31
|
101
|
537
|
1 314
|
1 500
|
2 604
|
1 786
|
0
|
197
|
1 383
|
|
| Minority Interest |
7 351
|
9 492
|
10 420
|
11 553
|
13 267
|
14 887
|
15 513
|
17 313
|
18 646
|
20 418
|
14 907
|
14 656
|
15 791
|
|
| Other Liabilities |
2 667
|
2 918
|
2 975
|
3 286
|
3 393
|
3 436
|
3 781
|
4 839
|
5 817
|
6 421
|
6 370
|
6 623
|
7 311
|
|
| Total Liabilities |
35 204
N/A
|
30 836
-12%
|
32 211
+4%
|
35 447
+10%
|
35 803
+1%
|
39 780
+11%
|
43 629
+10%
|
53 224
+22%
|
56 999
+7%
|
61 154
+7%
|
48 984
-20%
|
48 752
0%
|
56 332
+16%
|
|
| Equity | ||||||||||||||
| Common Stock |
24 453
|
24 453
|
24 453
|
24 453
|
24 453
|
24 453
|
24 453
|
24 453
|
24 453
|
24 453
|
24 453
|
24 453
|
24 453
|
|
| Retained Earnings |
29 260
|
40 529
|
44 147
|
47 197
|
53 704
|
53 860
|
56 051
|
75 648
|
57 608
|
66 901
|
72 188
|
63 662
|
71 367
|
|
| Additional Paid In Capital |
15 328
|
15 328
|
15 328
|
15 328
|
15 328
|
15 328
|
15 328
|
15 328
|
15 328
|
15 328
|
15 328
|
15 328
|
15 328
|
|
| Unrealized Security Profit/Loss |
985
|
2 037
|
807
|
1 458
|
771
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19 463
|
|
| Treasury Stock |
2 298
|
2 298
|
2 298
|
2 298
|
2 298
|
2 298
|
2 298
|
2 298
|
2 298
|
2 298
|
2 298
|
2 298
|
2 298
|
|
| Other Equity |
5 030
|
5 098
|
5 097
|
5 050
|
5 050
|
3 456
|
6 436
|
6 018
|
1 479
|
4 200
|
2 655
|
5 201
|
9 321
|
|
| Total Equity |
62 697
N/A
|
74 952
+20%
|
77 340
+3%
|
81 088
+5%
|
86 909
+7%
|
87 887
+1%
|
87 098
-1%
|
107 113
+23%
|
93 611
-13%
|
100 184
+7%
|
112 326
+12%
|
106 346
-5%
|
118 993
+12%
|
|
| Total Liabilities & Equity |
97 901
N/A
|
105 788
+8%
|
109 551
+4%
|
116 535
+6%
|
122 711
+5%
|
127 667
+4%
|
130 727
+2%
|
160 337
+23%
|
150 611
-6%
|
161 338
+7%
|
161 311
0%
|
155 099
-4%
|
175 325
+13%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|